BASF SE (ETR: BAS)
Germany
· Delayed Price · Currency is EUR 45.61
+0.13 (0.27%)
Jan 21, 2025, 5:35 PM CET
BASF SE Revenue
BASF SE had revenue of 15.74B EUR in the quarter ending September 30, 2024, with 0.03% growth. This brings the company's revenue in the last twelve months to 65.27B, down -9.79% year-over-year. In the year 2023, BASF SE had annual revenue of 68.90B, down -21.10%.
Revenue (ttm)
65.27B
Revenue Growth
-9.79%
P/S Ratio
0.62
Revenue / Employee
582.40K
Employees
109,686
Market Cap
40.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 68.90B | -18.43B | -21.10% |
| Dec 31, 2022 | 87.33B | 8.73B | 11.11% |
| Dec 31, 2021 | 78.60B | 19.45B | 32.88% |
| Dec 31, 2020 | 59.15B | -167.00M | -0.28% |
| Dec 31, 2019 | 59.32B | -904.00M | -1.50% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Heidelberg Materials AG | 20.79B |
| Symrise AG | 4.88B |
| Covestro AG | 14.15B |
| Evonik Industries AG | 15.16B |
| Brenntag SE | 16.19B |
| Fuchs SE | 3.51B |
| Wacker Chemie AG | 5.77B |
| LANXESS Aktiengesellschaft | 6.32B |
BASF SE News
- 5 days ago - Construction Additives Global Strategic Business Report 2024-2030, Competitive Analysis of 45+ Select Players Including ATPL, BASF, Berolan, Chryso, Cico, Dow, Evonik, Fosroc, and Fritz-Pak - GlobeNewsWire
- 6 days ago - My Dividend Stock Portfolio: $10,000 In Dividends In 2024 - 97 Holdings With 13 Buys - Seeking Alpha
- 7 days ago - BASF to seek compensation from Clariant over ethylene market infringement - Seeking Alpha
- 7 days ago - Clariant Gets Damages Claim from BASF - The Wall Street Journal
- 7 days ago - Clariant Gets Damages Claim from BASF - WSJ
- 7 days ago - Clariant Gets Ethylene Purchasing Market Infringement Damages Claim from BASF - The Wall Street Journal
- 9 days ago - Medical Elastomer Market worth $14.27 billion by 2029, at a CAGR of 8.3 % says MarketsandMarkets™ - Benzinga
- 4 weeks ago - My Dividend Stock Portfolio: New November Dividend Record - 97 Holdings With 18 Buys - Seeking Alpha